Literature DB >> 22640618

Action of modafinil through histaminergic and orexinergic neurons.

Tomoko Ishizuka1, Tomotaka Murotani, Atsushi Yamatodani.   

Abstract

Modafinil is a wake-promoting drug used for the treatment of excessive daytime sleepiness due to narcolepsy as well as excessive sleepiness associated with obstructive sleep apnea and shift work disorder. Although the wake-promoting effect of modafinil is expressed through the dopaminergic and the norepinephrinergic systems similar to that of classical psychostimulants, the mechanism of action is distinct from those compounds in terms of the involvement of the histaminergic and the orexinergic systems. Modafinil activates the histaminergic system in an indirect manner, presumably via attenuation of the inhibitory GABAergic input to the histaminergic neurons. The orexinergic system controls arousal through the histaminergic system, and the modafinil-induced increment of histamine release is abolished in orexin neuron-ablated mice, suggesting that modafinil increases histaminergic tone via orexinergic neurons. Clinical and experimental investigations have suggested less importance of the orexinergic system in the wake-promoting effect of modafinil, but the orexinergic system is considered to be involved in modafinil-induced alertness or synaptic plasticity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22640618     DOI: 10.1016/B978-0-12-394623-2.00014-7

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  8 in total

1.  Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression.

Authors:  Carmela M Reichel; Meghin G Gilstrap; Lauren A Ramsey; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

2.  Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea.

Authors:  Man-Jeong Paik; Dong-Kyu Kim; Duc-Toan Nguyen; Gwang Lee; Chae Seo Rhee; In Young Yoon; Jeong-Whun Kim
Journal:  Sleep Breath       Date:  2014-01-09       Impact factor: 2.816

Review 3.  How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.

Authors:  Anthony T Reder; Xuan Feng
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

Review 4.  The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Authors:  Maddalena Mereu; Antonello Bonci; Amy Hauck Newman; Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2013-08-10       Impact factor: 4.530

Review 5.  Lifetime evolution of ADHD treatment.

Authors:  Federico Mucci; Barbara Carpita; Giovanni Pagni; Alessandra Della Vecchia; Sarah Bjedov; Andrea Pozza; Donatella Marazziti
Journal:  J Neural Transm (Vienna)       Date:  2021-05-15       Impact factor: 3.850

6.  Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.

Authors:  Giulia Fiscon; Federica Conte; Susanna Amadio; Cinzia Volonté; Paola Paci
Journal:  Neurotherapeutics       Date:  2021-05-13       Impact factor: 6.088

7.  Anesthetic management of a patient with narcolepsy by combination of total intravenous and regional anesthesia: a case report.

Authors:  Daiki Takekawa; Tetsuya Kushikata; Masato Kitayama; Kazuyoshi Hirota
Journal:  JA Clin Rep       Date:  2017-07-14

Review 8.  Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.

Authors:  Christopher H van Dyck; Amy F T Arnsten; Prasad R Padala; Olga Brawman-Mintzer; Alan J Lerner; Anton P Porsteinsson; Roberta W Scherer; Allan I Levey; Nathan Herrmann; Nimra Jamil; Jacobo E Mintzer; Krista L Lanctôt; Paul B Rosenberg
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-05       Impact factor: 4.105

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.